Data Integrity in hybrid systems: good practices for paper and electronic systems
Digitalization is advancing steadily in the pharmaceutical industry, but operational reality shows that many organizations continue to work […]
Digitalization is advancing steadily in the pharmaceutical industry, but operational reality shows that many organizations continue to work […]
Many technically correct pharmaceutical projects end up generating deviations, delays in qualification or difficulties in inspection for a common reason:
Requalification (often called periodic qualification) is a fundamental pillar in GMP regulations. In simple terms: It is not enough to
In the previous article we analyzed what changes Annex 15 brings and what key message the inspectors are sending, as well
Annex 15 – Qualification and Validation is one of the classic pillars of European GMP and, precisely because
In January 2026, the new GMP/GDP Inspectors Working Group (GMDP IWG) work plan came into effect.
Decommissioning GMP (Good Manufacturing Practices) equipment is the formal and documented process for removing equipment.
In the pharmaceutical industry, maintenance is not only a technical function aimed at the availability of assets. It's a
In the development of new facilities, manufacturing lines, automated systems or critical equipment in regulated environments, delays and
In the pharmaceutical industry, automated control systems are the basis for the safe, efficient and reproducible operation of products.